Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulating androgens

PURPOSE: Patients previously treated with ketoconazole were excluded from phase III trials of abiraterone acetate due to potential overlapping mechanism of action. The purpose of this study was to determine the clinical utility of abiraterone and its impact on circulating androgens following ketocon...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Cancer Res
Glavni autori: Kim, Won, Zhang, Li, Wilton, John H., Fetterly, Gerald, Mohler, James L., Weinberg, Vivian, Morse, Allison, Szmulewitz, Russell, Friedlander, Terence W., Fong, Lawrence, Lin, Amy M., Harzstark, Andrea, Molina, Arturo, Small, Eric J., Ryan, Charles J.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4277885/
https://ncbi.nlm.nih.gov/pubmed/25336698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-1595
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items